Literature DB >> 21774763

Role of Ca²+-sensitive K+ currents in controlling ventricular repolarization: possible implications for future antiarrhytmic drug therapy.

N Nagy1, Z Márton, L Kiss, A Varró, P P Nánási, A Tóth.   

Abstract

Normal heart function and repolarization of the cardiac action potential (AP) is to a high extent subjective to synchronized activity of sarcolemmal K(+) channels, expressed in both ventricular and atrial myocardium, largely contributing to regulation of the resting potential, the pacemaker activity, and the shape and duration of the AP. Clinical observations and experimental studies in cardiomyocytes and multicellular preparations provided firm evidence for the sensitivity of some major outward K+ currents and the corresponding ion channels to shifts in intracellular Ca(2+) concentration ([Ca(2+)](i)). Direct regulation via interaction between [Ca(2+ )](i) and the channel protein or indirect modulation via Ca(2+ ) signaling pathways of these currents have strong implications to mechanical and electrical performance of the heart, and its physiological adaptation to altered load. It may also lead to severe cardiac dysfunction, if [Ca(2+ )](i) handling is disturbed in a variety of pathological conditions. In this review we attempt to summarize the present state of the topic on two ubiquitous repolarizing K(+) currents (I(to1) and I(K1)) with documented Ca(2+)-sensitivity and critical significance in cellular antiarrhythmic defense, to highlight fields where clue data are missing, and discuss the apparently unsolved "mystery" of the cardiac small conductance Ca(2+ )-activated K(+ ) (SK) channels. We have collected the available information on the known novel, although usually still not enough selective inhibitors and activators of these currents justifying the need for more selective ones. Finally, we emphasize a few related therapeutical perspectives to be considered for future experimental research and particularly in pharmaceutical development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21774763     DOI: 10.2174/092986711796642463

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  9 in total

1.  Calm down when the heart is stressed: Inhibiting calmodulin-dependent protein kinase II for antiarrhythmias.

Authors:  Dayue Darrel Duan
Journal:  Trends Cardiovasc Med       Date:  2015-02-07       Impact factor: 6.677

2.  Unstructured to structured transition of an intrinsically disordered protein peptide in coupling Ca²⁺-sensing and SK channel activation.

Authors:  Miao Zhang; John M Pascal; Ji-Fang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

Review 3.  Targeting the Small- and Intermediate-Conductance Ca-Activated Potassium Channels: The Drug-Binding Pocket at the Channel/Calmodulin Interface.

Authors:  Meng Cui; Guangrong Qin; Kunqian Yu; M Scott Bowers; Miao Zhang
Journal:  Neurosignals       Date:  2014-10-08

4.  Differential modulation of SK channel subtypes by phosphorylation.

Authors:  Young-Woo Nam; Dezhi Kong; Dong Wang; Razan Orfali; Rinzhin T Sherpa; Jennifer Totonchy; Surya M Nauli; Miao Zhang
Journal:  Cell Calcium       Date:  2021-01-06       Impact factor: 6.817

5.  The Small Conductance Calcium-Activated Potassium Channel Inhibitors NS8593 and UCL1684 Prevent the Development of Atrial Fibrillation Through Atrial-Selective Inhibition of Sodium Channel Activity.

Authors:  Alexander Burashnikov; Hector Barajas-Martinez; Dan Hu; Victoria M Robinson; Morten Grunnet; Charles Antzelevitch
Journal:  J Cardiovasc Pharmacol       Date:  2020-08       Impact factor: 3.271

6.  PKA phosphorylation underlies functional recruitment of sarcolemmal SK2 channels in ventricular myocytes from hypertrophic hearts.

Authors:  Shanna Hamilton; Iuliia Polina; Radmila Terentyeva; Peter Bronk; Tae Yun Kim; Karim Roder; Richard T Clements; Gideon Koren; Bum-Rak Choi; Dmitry Terentyev
Journal:  J Physiol       Date:  2019-03-20       Impact factor: 5.182

7.  Identification of the functional binding pocket for compounds targeting small-conductance Ca²⁺-activated potassium channels.

Authors:  Miao Zhang; John M Pascal; Marcel Schumann; Roger S Armen; Ji-Fang Zhang
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

Review 8.  Investigational Anti-Atrial Fibrillation Pharmacology and Mechanisms by Which Antiarrhythmics Terminate the Arrhythmia: Where Are We in 2020?

Authors:  Alexander Burashnikov
Journal:  J Cardiovasc Pharmacol       Date:  2020-11       Impact factor: 3.271

9.  Increased Ca2+ content of the sarcoplasmic reticulum provides arrhythmogenic trigger source in swimming-induced rat athlete's heart model.

Authors:  Péter Gazdag; Kinga Oravecz; Károly Acsai; Vivien Demeter-Haludka; Balázs Ördög; Jozefina Szlovák; Zsófia Kohajda; Alexandra Polyák; Bálint András Barta; Attila Oláh; Tamás Radovits; Béla Merkely; Julius Gy Papp; István Baczkó; András Varró; Norbert Nagy; János Prorok
Journal:  Sci Rep       Date:  2020-11-11       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.